This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 May;26(5):370.

doi: 10.1016/j.cardfail.2020.04.013.

Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19

Biykem Bozkurt, Richard Kovacs, Bob Harrington

PMID: 32439095
PMCID: PMC7234783
DOI: 10.1016/j.cardfail.2020.04.013

Editorial

Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19

Biykem Bozkurt et al. J Card Fail. 2020 May.

. 2020 May;26(5):370.

doi: 10.1016/j.cardfail.2020.04.013.

Authors

Biykem Bozkurt, Richard Kovacs, Bob Harrington

PMID: 32439095
PMCID: PMC7234783
DOI: 10.1016/j.cardfail.2020.04.013

No abstract available

PubMed Disclaimer

Similar articles

Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
Turgeon RD, Zieroth S, Bewick D, Chow CM, Clarke B, Cowan S, Fordyce CB, Fournier A, Gin K, Gupta A, Hardiman S, Jackson S, Lau B, Leong-Poi H, Mansour S, Marelli A, Quraishi AR, Roifman I, Ruel M, Sapp J, Singh G, Small G, Virani S, Wood DA, Krahn A. Turgeon RD, et al. Can J Cardiol. 2020 Aug;36(8):1180-1182. doi: 10.1016/j.cjca.2020.05.033. Epub 2020 Jun 2. Can J Cardiol. 2020. PMID: 32502522 Free PMC article. No abstract available.
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
Brojakowska A, Narula J, Shimony R, Bander J. Brojakowska A, et al. J Am Coll Cardiol. 2020 Jun 23;75(24):3085-3095. doi: 10.1016/j.jacc.2020.04.028. Epub 2020 Apr 16. J Am Coll Cardiol. 2020. PMID: 32305401 Free PMC article. Review.
Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?
Vitiello A, Ferrara F. Vitiello A, et al. Eur J Pharmacol. 2020 Sep 15;883:173373. doi: 10.1016/j.ejphar.2020.173373. Epub 2020 Jul 15. Eur J Pharmacol. 2020. PMID: 32679185 Free PMC article.
COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
Siniorakis E, Arvanitakis S, Nikolopoulos I, Elkouris M. Siniorakis E, et al. mBio. 2020 May 22;11(3):e00946-20. doi: 10.1128/mBio.00946-20. mBio. 2020. PMID: 32444383 Free PMC article. No abstract available.
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.
Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C. Wang JJ, et al. Pharmacol Ther. 2020 Nov;215:107628. doi: 10.1016/j.pharmthera.2020.107628. Epub 2020 Jul 9. Pharmacol Ther. 2020. PMID: 32653530 Free PMC article. Review.

See all similar articles

Cited by

The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences.
Maranduca MA, Tanase DM, Cozma CT, Dima N, Clim A, Pinzariu AC, Serban DN, Serban IL. Maranduca MA, et al. Pharmaceutics. 2022 Sep 8;14(9):1906. doi: 10.3390/pharmaceutics14091906. Pharmaceutics. 2022. PMID: 36145655 Free PMC article. Review.
COVID-19 - A vascular disease.
Siddiqi HK, Libby P, Ridker PM. Siddiqi HK, et al. Trends Cardiovasc Med. 2021 Jan;31(1):1-5. doi: 10.1016/j.tcm.2020.10.005. Epub 2020 Oct 14. Trends Cardiovasc Med. 2021. PMID: 33068723 Free PMC article. Review.
Coronavirus Disease 2019 and Takotsubo Syndrome.
Zhou L, Chen Z, Jiang R, Hu Y, Zhu B, Yang C, Yang L, Liu C. Zhou L, et al. Rev Cardiovasc Med. 2022 Sep 5;23(9):298. doi: 10.31083/j.rcm2309298. eCollection 2022 Sep. Rev Cardiovasc Med. 2022. PMID: 39077710 Free PMC article. Review.
Long-term complications of COVID-19.
Desai AD, Lavelle M, Boursiquot BC, Wan EY. Desai AD, et al. Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C1-C11. doi: 10.1152/ajpcell.00375.2021. Epub 2021 Nov 24. Am J Physiol Cell Physiol. 2022. PMID: 34817268 Free PMC article. Review.
Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies.
Faour WH, Choaib A, Issa E, Choueiry FE, Shbaklo K, Alhajj M, Sawaya RT, Harhous Z, Alefishat E, Nader M. Faour WH, et al. Inflamm Res. 2022 Jan;71(1):39-56. doi: 10.1007/s00011-021-01520-8. Epub 2021 Nov 21. Inflamm Res. 2022. PMID: 34802072 Free PMC article. Review.

See all "Cited by" articles

References

1. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb 28 doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
1. Huang C. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
1. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. - DOI - PMC - PubMed
1. Hoffmann M. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Mar 4 doi: 10.1016/j.cell.2020.02.052. pii: S0092-8674(20)30229-4. - DOI - PMC - PubMed
1. Ferrario C.M. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005 May 24;111(20):2605–2610. Epub 2005 May 16. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information